[HTML][HTML] Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - nature.com
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens… - Nature …, 2021 - researchinformation.amsterdamumc …
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
[PDF][PDF] Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens, M Timmermans, M Smid… - pure.eur.nl
Results Spatial contexture of lymphocytes but not myeloid cells is prognostic in TNBC. In
order to assess tumor-immune interactions in TNBC, CD8+ T cell presence and spatial …
order to assess tumor-immune interactions in TNBC, CD8+ T cell presence and spatial …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - ideas.repec.org
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens… - Nature …, 2021 - pubmed.ncbi.nlm.nih.gov
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens… - Nature …, 2021 - ui.adsabs.harvard.edu
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - europepmc.org
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
[HTML][HTML] Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens, M Timmermans… - Nature …, 2021 - ncbi.nlm.nih.gov
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
D Hammerl, JWM Martens… - Nature …, 2021 - search.ebscohost.com
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer
D Hammerl, JWM Martens… - Nature …, 2021 - econpapers.repec.org
Only a subgroup of triple-negative breast cancer (TNBC) responds to immune checkpoint
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …
inhibitors (ICI). To better understand lack of response to ICI, we analyze 681 TNBCs for …